IP Library › Granted Patent US 10,793,923
Granted Patent B2
US 10,793,923 · App. 15/726,732 · Granted Oct 6, 2020

Compositions and methods for detection of BK virus

Inventors: Rochak Mehta (Fremont, CA); Jingtao Sun (San Ramon, CA)
Assignee: Roche Molecular Systems, Inc.
C12Q1/701C12Q1/686G01N33/56983C12N2710/22011C12Q2600/16G01N2333/025Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,793,923
App. No.
15/726,732
Granted
Oct 6, 2020
Kind
B2
Abstract

Methods for the rapid detection of the presence or absence of BK virus in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers and probes targeting BK virus and kits are provided that are designed for the detection of BK virus.

Claims (9)

1. A method of detecting BK virus in a sample, the method comprising: (a) performing an amplifying step comprising contacting the sample with a set of primers to produce an amplification product, if a target nucleic acid of BK Virus is present in the sample; (b) performing a hybridization step comprising contacting the amplification product, if a target nucleic acid is present in the sample, with a probe; and (c) detecting the presence or absence of the amplification product, wherein the presence of the amplification product is indicative of the presence of BK virus in the sample, and wherein the absence of the amplification product is indicative of the absence of BK virus in the sample; wherein the set of primers consists of a first primer consisting of SEQ ID NO:4, and a second primer consisting of SEQ ID NO:5, and wherein the probe consists of SEQ ID NO:3 and optionally a label.

2. The method of claim 1 ,

wherein the hybridization step comprises contacting the amplification product with the probe, wherein the probe is labeled with a donor fluorescent moiety and a corresponding acceptor moiety;

wherein the detecting step comprises detecting the presence or absence of fluorescence resonance energy transfer (FRET) between the donor fluorescent moiety and the acceptor moiety of the probe; and

wherein the presence or absence of fluorescence is indicative of the presence of absence of BK Virus in the sample.

3. The method of claim 2 , wherein the amplification step comprises a polymerase enzyme having 5′ to 3′ nuclease activity.

4. The method of claim 2 , wherein the acceptor moiety is a quencher.

5. The method of claim 1 , wherein the sample is a biological sample.

6. The method of claim 5 , wherein the biological sample is blood, plasma, or urine.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2017
From: MEHTA, ROCHAK; SUN, JINGTAO
To: ROCHE MOLECULAR SYSTEMS, INC.
Reel/Frame 043827/0875 →
Continuity (2)
Provisional Application 62419853 · Nov 9, 2016
Related Publication 20180127838A1 · May 10, 2018